Biosign Flu a + B, Status Flu a & B

FDA 510(k) K133474 · Princeton BioMeditech Corp.

Substantially Equivalent

510(k) numberK133474

Submission

Device name
Biosign Flu a + B, Status Flu a & B
Applicant
Princeton BioMeditech Corp.
Monmouth Junction, NJ, US
Received
November 12, 2013
Decision date
December 10, 2013
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PSZ – Devices Detecting Influenza A, B, And C Virus Antigens
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3328
Specialty
Microbiology

An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.

Other 510(k)s with product code PSZ

510(k)DeviceApplicantDecision
K254262Sofia Influenza A+B FIA; Sofia RSV FIA; Sofia Strep A+ FIAPSZ · Dual Track Ortho Clinical Diagnostics Inc. (QuidelOrtho)09/04/2026SE
K252283Nano-Check Influenza A+B TestPSZ · Dual Track Nano-Ditech Corporation01/15/2026SE
K250398Innovita Flu A/B Antigen Rapid TestPSZ · Traditional Innovita (Tangshan) Biological Technology Co.…07/03/2025SE
K241188Acucy® Influenza A&B Test with the Acucy® 2 SystemPSZ · Dual Track SEKISUI Diagnostics, LLC04/18/2025SE
K232434BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived KitPSZ · Traditional Bd12/05/2023SE
K223016BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitPSZ · Traditional Bd01/27/2023SE
K192719Osom Ultra Plus Flu A&B Test KitPSZ · Dual Track SEKISUI Diagnostics, LLC04/03/2020SE
K191514CareStart Flu A&B PlusPSZ · Dual Track Access Bio, Inc.02/18/2020SE
K182001Acucy Influenza A&B Test with the Acucy SystemPSZ · Dual Track SEKISUI Diagnostics, LLC12/17/2018SE
K182157BioSign Flu A+BPSZ · Special Princeton BioMeditech Corp.09/18/2018SE

More from Princeton BioMeditech Corp.

510(k)DeviceDecision
K251538Status™ COVID-19/Flu A&BSCA · Dual Track 11/14/2025SE
K182157BioSign Flu A+BPSZ · Special 09/18/2018SE
K130650Status DS OxyDJG · Traditional 02/26/2014SE
K132465Biosign Flu a + B, Status Flu a & BPSZ · Special 09/09/2013SE
K083746Biosign Flu A+BPSZ · Traditional 11/10/2010SE
K100817Biosign Ifobtest, Biosign Fecal Occult Blood TestKHE · Traditional 07/01/2010SE
K100341Spermcheck FertilityPOV · Traditional 05/04/2010SE
K082661Biostrep a, Biosign Strep a, Statusfirst Strep aGTY · Special 10/06/2008SE
K073039Spermcheck VasectomyPOV · Traditional 01/24/2008SE
K062575Modification to: Accusign RC Doa 10 (Met/Opi/Coc/Thc/Pcp/Bzo/Bar/Mtd/Tca/AmpLAG · Traditional 11/26/2007SE

Questions and answers

When was Biosign Flu a + B, Status Flu a & B cleared by the FDA?

Biosign Flu a + B, Status Flu a & B (K133474) received a 510(k) decision of Substantially Equivalent on December 10, 2013, 28 days after the submission was received.

What is the product code of K133474?

The FDA product code is PSZ – Devices Detecting Influenza A, B, And C Virus Antigens, a Class II (moderate risk) device regulated under 21 CFR 866.3328.